4 results match your criteria: "Centre Léon Bérard (CLB) and University of Lyon 1[Affiliation]"
Bio Protoc
March 2024
Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), Lyon, France.
Diatoms serve as a source for a variety of compounds with particular biotechnological interest. Therefore, redirecting the flow to a specific pathway requires the elucidation of the gene's specific function. The most commonly used method in diatoms is biolistic transformation, which is a very expensive and time-consuming method.
View Article and Find Full Text PDFBio Protoc
February 2024
Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), Lyon, France.
Inflammatory bowel disease (IBD) is characterized by an aberrant immune response against microbiota. It is well established that T cells play a critical role in mediating the pathology. Assessing the contribution of each subset of T cells in mediating the pathology is crucial in order to design better therapeutic strategies.
View Article and Find Full Text PDFFront Immunol
September 2023
Department of Microbiology, Immunology and Molecular Genetics, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, United States.
J Clin Invest
April 2022
Tumor Escape Resistance and Immunity Department, Cancer Research Center of Lyon (CRCL), INSERM U1052, CNRS UMR 5286, Centre Léon Bérard (CLB) and University of Lyon 1, Lyon, France.
SMAD4, a mediator of TGF-β signaling, plays an important role in T cells to prevent inflammatory bowel disease (IBD). However, the precise mechanisms underlying this control remain elusive. Using both genetic and epigenetic approaches, we revealed an unexpected mechanism by which SMAD4 prevents naive CD8+ T cells from becoming pathogenic for the gut.
View Article and Find Full Text PDF